Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2002
03/20/2002EP1187853A2 Diagnostic uses of antibodies against acetylcholinesterase or c-terminal peptides thereof
03/20/2002EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
03/20/2002EP1187851A1 Novel integrin alpha subunit and uses thereof
03/20/2002EP1187845A2 Tumor suppressor molecules and methods of use
03/20/2002EP1187843A1 Angiogenic proteins and uses thereof
03/20/2002EP1187842A1 Human tumor necrosis factor receptor tr10
03/20/2002EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy
03/20/2002EP1187634A1 Cell growth inhibition
03/20/2002EP1187633A1 Use of anti-vegf antibody to enhance radiation in cancer therapy
03/20/2002EP1187632A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
03/20/2002EP1187630A1 Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens
03/20/2002EP1187591A2 Ibd-associated microbial antigens and methods of using same
03/20/2002EP1139101A9 Immunoassay for c-reactive protein
03/20/2002EP0628077B1 Humanised antibodies directed against a33 antigen
03/20/2002EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration
03/20/2002EP0418316B1 Platelet-specific chimeric immunoglobulin
03/20/2002CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof
03/20/2002CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins
03/20/2002CN1341120A 骨刺激因子 Bone stimulator
03/20/2002CN1340624A Polypeptide-human cathepsin 10.12 and polynucleotide for coding it
03/20/2002CN1340623A Polypeptide-glycosyl hydrolase 33.55 and polynucleotide for coding it
03/20/2002CN1340622A Polypeptide-serine/threonine protein kinase MO1511.11 and polynucleotide for coding it
03/20/2002CN1340621A Polypeptide-human casein kinase II alpha subunit 22.44 and polynucleotide for coding it
03/20/2002CN1340620A Polypeptide-human phosphoryl choline/ethanolamine transferase 22.99 and polynucleotide for coding it
03/20/2002CN1340619A Polypeptide-hydrogenase 9.13 and polynucleotide for coding it
03/20/2002CN1340618A Polypeptide-nucleotide reductase 13.31 and polynucleotide for coding it
03/20/2002CN1340617A Polypeptide-phosphoribosyl glycinamide synthetase 26.39 and polynucleotide for coding it
03/20/2002CN1340616A Polypeptide-human fructose-6-phosphate, 2-kinase/fructose-2,6-diphosphatase 14.08 and polynucleotide for coding it
03/20/2002CN1340615A Polypeptide-human uracil mononucleotide synthetase 42.79 and polynucleotide for coding it
03/20/2002CN1340548A Decontamination and application of human recombined cartilage oligo-substrate protein
03/20/2002CN1340547A Polypeptide-human eukaryotic initiation factor-2 (eIF-2)-associated protein 74.14 and polynucleotide for coding it
03/20/2002CN1340546A Polypeptide-human zinc finger protein 45.87 and polynucleotide for coding it
03/20/2002CN1340545A Polypeptide-human mammary gland susceptible gene coded protein 68.42 and polynucleotide for coding it
03/20/2002CN1340544A Polypeptide-human macroprotein 10.23 and polynucleotide for coding it
03/20/2002CN1340543A Polypeptide-human cell wither associated protein 13.31 and polynucleotide for coding it
03/20/2002CN1340542A Polypeptide-human transcription binding factor gamma subunit (CBF-C) 13.42 and polynucleotide for coding it
03/20/2002CN1340541A Polypeptide-humn Dnaj protein 14.85 and polynucleotide for coding it
03/20/2002CN1340540A Polypeptide-human syntenin protein 38.28 and polynucleotide for coding it
03/20/2002CN1340539A Polypeptide-clathrin light chain 49.5 and polynucleotide for coding it
03/20/2002CN1340538A Polypeptide-ribosomal protein S18-9.46 and polynucleotide for coding it
03/20/2002CN1340537A Polypeptide-human cyclophilin-40-13.2 and polynucleotide for coding it
03/20/2002CN1340536A Polypeptide-human glutamate receptor action protein 33.77 and polynucleotide for coding it
03/20/2002CN1340535A Polypeptide-human macroprotein 12.10 and polynucleotide for coding it
03/20/2002CN1340534A Polypeptide-human caudal action protein 17.38 and polynucleotide for coding it
03/20/2002CN1340533A Polypeptide-dihydrofolate reductase 25.19 and polynucleotide for coding it
03/20/2002CN1340532A Polypeptide-human erythrocyte kytoplasm protein 11 and polynucleotide for coding it
03/20/2002CN1340531A Polypeptide-human golgin-84 protein 11.88 and polynucleotide for coding it
03/20/2002CN1340530A Polypeptide-human macroprotein 10.34 and polynucleotide for coding it
03/20/2002CN1340529A Polypeptide-human shear factor 14.63 and polynucleotide for coding it
03/20/2002CN1340528A Polypeptide-human transcription control factor ZFM1 isomer 12.54 and polynucleotide for coding it
03/20/2002CN1340527A Polypeptide-lymphocyte activator protein 33 and polynucleotide for coding it
03/20/2002CN1340526A Polypeptide-proteasome HC2 subunit 64.57 and polynucleotide for coding it
03/20/2002CN1340525A Polypeptide-human snRNP auxilin Sm 13.64 and polynucleotide for coding it
03/20/2002CN1340524A Polypeptide-human cytochrome bcl compound core protein II 12.21 and polynucleotide for coding it
03/20/2002CN1340523A Polypeptide-human cell wither associated protein 11.44 and polynucleotide for coding it
03/20/2002CN1340522A Polypeptide-human mitochondrial translation initiation factor 20.90 and polynucleotide for coding it
03/20/2002CN1340521A Polypeptide-mechanocyte tropomyosin TM30p112.1 and polynucleotide for coding it
03/20/2002CN1340520A Polypeptide-polyadenylate bindin 33.11 and polynucleotide for coding it
03/20/2002CN1340519A Polypeptide-human cap binding protein 14.08 and polynucleotide for coding it
03/20/2002CN1340518A Polypeptide-human clustering and elongating protein 9.13 and polynucleotide for coding it
03/20/2002CN1340517A Polypeptide-human nucleotide excision repair protein 13.75 and polynucleotide for coding it
03/20/2002CN1340516A Polypeptide-abnormal human cDNA (B120) 14.63 containing CAG repetitive sequence and polynucleotide for coding it
03/20/2002CN1340515A Polypeptide-protein 39.16 containing SH3 structure domain and polynucleotide for coding it
03/20/2002CN1340514A Polypeptide-human U4/U6 small nuclear RNA bindin (U4/U6 snRNP) 13.09 and polynucleotide for coding it
03/20/2002CN1340513A Polypeptide-human cyclophilin-40-14.63 and polynucleotide for coding it
03/20/2002CN1340512A Polypeptide-Pax protein 12.10 and polynucleotide for coding it
03/20/2002CN1340511A Polypeptide-human neuronectin 29.81 and polynucleotide for coding it
03/20/2002CN1340510A Polypeptide-human cytokine receptor 11.88 and polynucleotide for coding it
03/20/2002CN1340509A Polypeptide-human brain macroprotein 9.68 and polynucleotide for coding it
03/19/2002USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110.
03/19/2002US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders
03/19/2002US6359126 Antibodies to αvβ3 integrin
03/19/2002US6359118 Carbohydrate crosslinked glycoprotein crystals
03/19/2002US6359116 Compounds
03/19/2002US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression
03/19/2002US6358920 Nonapeptide anticarcinogenic and antimetastasis agents
03/19/2002US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects
03/19/2002US6358733 Plasmid for use in the expression of heterologous genetically engineered polypeptides
03/19/2002US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections
03/19/2002US6358723 Deoxyribonuclease IIβ proteins and cDNAs
03/19/2002US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
03/19/2002US6358708 Nucleotide sequence coding segment of enzymatic polypeptide; for use in treatment and prevention of fungal infections; fungicides
03/19/2002US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002US6358704 M protein
03/19/2002US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell
03/19/2002US6358693 AMPA-binding human gluR4 receptor methods
03/19/2002US6358510 ICAM-1 derivatives with altered ability to bind LFA-1
03/19/2002US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors
03/19/2002US6358489 Fluorination of proteins and peptides for F-18 positron emission tomography
03/19/2002US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures
03/19/2002CA2099779C Mixed specificity fusion proteins
03/15/2002CA2357074A1 Novel bcl-2 related proline rich protein (bpr)
03/14/2002WO2002021141A2 Methods and compositions for diseases associated with amyloidosis
03/14/2002WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
03/14/2002WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002WO2002020809A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin
03/14/2002WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020786A2 Kinase d interacting protein